AT THE START OF 2018, seven senior employees assumed new roles at Roswell Park Cancer Institute in Buffalo, New York. Five of these program leaders were promoted or reappointed, and two have newly joined the Institute from other centers around the United States.
Meet the Appointees
Charles LeVea, MD, PhD, has been appointed Chair of the Roswell Park Department of Pathology and Laboratory Medicine, following a national search. Dr. LeVea, who had served as Interim Chair of the department for about a year, was recruited to Roswell Park as Assistant Professor of Oncology in 2003. Since then, he was appointed Director of Surgical Pathology, Associate Professor of Oncology, and Vice Chair of the Department of Pathology and Laboratory Medicine/Director of Anatomic Pathology.
Gissou Azabdaftari, MD, was named Clinical Chief of Cytopathology. Dr. Azabdaftari joined Roswell Park’s staff in 2010 and today holds a joint appointment as Associate Professor of Oncology within the Departments of Pathology & Laboratory Medicine and Urology. She works closely with the Institute’s clinicians to streamline processes to provide quicker diagnoses for patients. Dr. Azabdaftari is Head of Roswell Park’s Genitourinary Pathology Program.
Amy Case, MD, has been named the inaugural Chair of the Department of Supportive Care at Roswell Park Cancer Institute. Dr. Case also holds joint appointments as Palliative Medicine Fellowship Program Director at the University at Buffalo and Associate Professor in the University at Buffalo’s Division of Geriatrics and Palliative Medicine.
Holly Bowser, MBA, CMPE, is the new Vice President of Organizational Performance Improvement. Before coming to Roswell Park Cancer Institute, she worked as Vice President at Catholic Health.
Thomas Summerill, MBA, MHSA, is the new Executive Director of Payer Relations. He joins Roswell Park Cancer Institute from the University of Maryland Quality Care Network, where he served as Executive Director.
Sara Randolph was named Director of Payer Relations. She has been at Roswell Park Cancer Institute for 3 years, working as Administrator of Managed Care Operations.
David Tear, MBA
David Tear, MBA, has rejoined Roswell Park after a brief absence, in the new position of Senior Executive Director for Disease Site Strategy Group Implementation and Management. He served as Executive Director of Ambulatory Care Services at Roswell Park from 2014 to 2016. ■
